LPCN

Lipocine News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Lipocine Inc LPCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.001 -0.12% 0.80 00:00:00
Open Price Low Price High Price Close Price Prev Close
0.789 0.7862 0.83 0.80 0.801
more quote information »

Recent News

Date Time Source Heading
6/28/202216:07EDGARCurrent Report Filing (8-k)
6/14/202208:01EDGARCurrent Report Filing (8-k)
6/14/202208:00PRNUSLIPOCINE GRANTED US PATENTS DIRECTED TO CNS AND LIVER..
6/10/202216:11EDGARCurrent Report Filing (8-k)
6/10/202211:36EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202211:36EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202211:34EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202211:34EDGARStatement of Changes in Beneficial Ownership (4)
6/10/202211:33EDGARStatement of Changes in Beneficial Ownership (4)
6/06/202216:04EDGARCurrent Report Filing (8-k)
6/06/202216:00PRNUSLIPOCINE ANNOUNCES PRESENTATION AT 2022 EPILEPSY FOUNDATION..
5/16/202218:45EDGARStatement of Changes in Beneficial Ownership (4)
5/12/202209:01EDGARCurrent Report Filing (8-k)
5/12/202209:00EDGARCurrent Report Filing (8-k)
5/12/202208:00PRNUSLipocine Announces Positive LPCN 1144 NASH Open Label..
5/09/202208:04EDGARQuarterly Report (10-q)
5/09/202208:01EDGARCurrent Report Filing (8-k)
5/09/202208:00PRNUSLipocine Announces Financial Results for the First Quarter..
4/22/202216:06EDGARProxy Statement (definitive) (def 14a)
4/12/202217:01EDGARStatement of Changes in Beneficial Ownership (4)
4/12/202216:59EDGARInitial Statement of Beneficial Ownership (3)
4/11/202208:02EDGARCurrent Report Filing (8-k)
4/11/202208:00PRNUSLIPOCINE ANNOUNCES BOARD of DIRECTOR APPOINTMENTS
4/01/202216:06EDGARCurrent Report Filing (8-k)
3/29/202207:05PRNUSLIPOCINE ANNOUNCES ITS PARTNER RECEIVED FDA APPROVAL OF..
3/09/202209:08SEEKLipocine GAAP EPS of -$0.01, revenue of $16.1M
3/09/202208:02EDGARAnnual Report (10-k)
3/09/202208:01EDGARCurrent Report Filing (8-k)
3/09/202208:00PRNUSLipocine Announces Financial Results for the Year Ended..
3/07/202216:06EDGARAmended Current Report Filing (8-k/a)
3/01/202208:00PRNUSLipocine Announces Regulatory Guidance on LPCN 1144 in..
2/03/202209:34SEEKLipocine announces FDA accepted the marketing application..
2/03/202208:01EDGARCurrent Report Filing (8-k)
2/03/202208:00PRNUSLIPOCINE ANNOUNCES ITS PARTNER RECEIVED FDA ACCEPTANCE OF..
1/27/202209:15EDGARInitial Statement of Beneficial Ownership (3)
1/27/202208:01EDGARCurrent Report Filing (8-k)
1/27/202208:00PRNUSLipocine Announces Peer-Reviewed Publication of Phase 3..
1/21/202216:01EDGARCurrent Report Filing (8-k)
1/14/202217:14EDGARCurrent Report Filing (8-k)
1/05/202208:00PRNUSLipocine to Present Clinical Data on LPCN 1144 at 2022..
1/04/202208:01EDGARCurrent Report Filing (8-k)
12/22/202111:22EDGARCurrent Report Filing (8-k)
12/22/202109:05SEEKDosing underway in Lipocine's mid-stage LPCN 1148 study for..
12/22/202108:00PRNUSLIPOCINE ANNOUNCES PATIENT DOSED IN ITS PHASE 2 STUDY WITH..
12/08/202116:01EDGARStatement of Changes in Beneficial Ownership (4)
12/08/202116:01EDGARStatement of Changes in Beneficial Ownership (4)
11/10/202108:09SEEKLipocine EPS beats by $0.01
11/10/202108:04EDGARCurrent Report Filing (8-k)
11/10/202108:01EDGARQuarterly Report (10-q)
11/10/202108:00PRNUSLipocine Announces Financial Results for the Third Quarter..


Your Recent History
NASDAQ
LPCN
Lipocine
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.